JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cropley, V. L.
Right arrow Articles by Innis, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cropley, V. L.
Right arrow Articles by Innis, R. B.
Journal of Nuclear Medicine Vol. 47 No. 1 100-104
© 2006 by Society of Nuclear Medicine


Basic Science Investigation

Whole-Body Biodistribution and Estimation of Radiation-Absorbed Doses of the Dopamine D1 Receptor Radioligand 11C-NNC 112 in Humans

Vanessa L. Cropley, BSc1, Masahiro Fujita, MD, PhD1, John L. Musachio, PhD1, Jinsoo Hong, MS1, Subroto Ghose, MD, PhD1, Janet Sangare, C-RNP1, Pradeep J. Nathan, PhD2, Victor W. Pike, PhD1 and Robert B. Innis, MD; PhD1

1 Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland; and 2 Department of Physiology, Monash Centre for Brain and Behaviour, Monash University, Clayton, Victoria, Australia

Correspondence: For correspondence or reprints contact: Vanessa L. Cropley, BSc, Molecular Imaging Branch, NIMH, National Institute of Health, Bldg. 1, Room B3-10, 1 Center Dr., MSC 0135, Bethesda, MD 20892-0135. E-mail: cropleyv{at}mail.nih.gov

The present study estimated radiation-absorbed doses of the dopamine D1 receptor radioligand [11C]((+)-8-chloro-5-(7-benzofuranyl)-7-hydroxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine) (NNC 112) in humans, based on dynamic whole-body PET in healthy subjects. Methods: Whole-body PET was performed on 7 subjects after injection of 710 ± 85 MBq of 11C-NNC 112. Fourteen frames were acquired for a total of 120 min in 7 segments of the body. Regions of interest were drawn on compressed planar images of source organs that could be identified. Radiation dose estimates were calculated from organ residence times using the OLINDA 1.0 program. Results: The organs with the highest radiation-absorbed doses were the gallbladder, liver, lungs, kidneys, and urinary bladder wall. Biexponential fitting of mean bladder activity demonstrated that 15% of activity was excreted via the urine. With a 2.4-h voiding interval, the effective dose was 5.7 µSv/MBq (21.1 mrem/mCi). Conclusion: 11C-NNC 112 displays a favorable radiation dose profile in humans and would allow multiple PET examinations per year to be performed on the same subject.

Key Words: 11C-NNC 112 • PET • D1 receptor • dosimetry • effective dose




This article has been cited by other articles:


Home page
JNMHome page
N. Liu, M. Li, X. Li, X. Meng, G. Yang, S. Zhao, Y. Yang, L. Ma, Z. Fu, and J. Yu
PET-Based Biodistribution and Radiation Dosimetry of Epidermal Growth Factor Receptor-Selective Tracer 11C-PD153035 in Humans
J. Nucl. Med., February 1, 2009; 50(2): 303 - 308.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. R. Virta, T. Tolvanen, K. Nagren, A. Bruck, A. Roivainen, and J. O. Rinne
1-11C-Methyl-4-Piperidinyl-N-Butyrate Radiation Dosimetry in Humans by Dynamic Organ-Specific Evaluation
J. Nucl. Med., March 1, 2008; 49(3): 347 - 353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.